Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Net Cash Flow: 2013-2024

Historic Net Cash Flow for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to $101.9 million.

  • Wave Life Sciences' Net Cash Flow fell 107.79% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.6 million, marking a year-over-year decrease of 167.03%. This contributed to the annual value of $101.9 million for FY2024, which is 8.98% down from last year.
  • Per Wave Life Sciences' latest filing, its Net Cash Flow stood at $101.9 million for FY2024, which was down 8.98% from $112.0 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Net Cash Flow registered a high of $112.0 million during FY2023, and its lowest value of -$61.8 million during FY2022.
  • In the last 3 years, Wave Life Sciences' Net Cash Flow had a median value of $101.9 million in 2024 and averaged $50.7 million.
  • As far as peak fluctuations go, Wave Life Sciences' Net Cash Flow slumped by 190.61% in 2021, and later skyrocketed by 281.07% in 2023.
  • Over the past 5 years, Wave Life Sciences' Net Cash Flow (Yearly) stood at $37.2 million in 2020, then plummeted by 190.61% to -$33.7 million in 2021, then tumbled by 83.39% to -$61.8 million in 2022, then spiked by 281.07% to $112.0 million in 2023, then decreased by 8.98% to $101.9 million in 2024.